NO20091231L - Polymorf av (R)-3-(2-hydroksy-2, 2-difenyl-acetoksy)-1-(isoksazol-S-ylcarbamoyl-metyl)-1-azoni A-bicyklo-[2,2,2]oktanbromid - Google Patents

Polymorf av (R)-3-(2-hydroksy-2, 2-difenyl-acetoksy)-1-(isoksazol-S-ylcarbamoyl-metyl)-1-azoni A-bicyklo-[2,2,2]oktanbromid

Info

Publication number
NO20091231L
NO20091231L NO20091231A NO20091231A NO20091231L NO 20091231 L NO20091231 L NO 20091231L NO 20091231 A NO20091231 A NO 20091231A NO 20091231 A NO20091231 A NO 20091231A NO 20091231 L NO20091231 L NO 20091231L
Authority
NO
Norway
Prior art keywords
ylcarbamoylmethyl
diphenylacetoxy
isoxazol
bicyclo
hydroxy
Prior art date
Application number
NO20091231A
Other languages
English (en)
Inventor
Stephanie Monnier
Gerhard Muhrer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20091231L publication Critical patent/NO20091231L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Det beskrives en ny, polymorfisk krystallform-n av (R)-3-(2-hydroksy-2,2-difénylacetoksy)-l-(isoksazol-3-ylkarbamoyl-metyl)-l-azonia-bisyklo-[2.2.2]oktan bromid, angitt som krystallform Ta.Det beskrives videre metoder for fremstilling av produktet og bruken av denne krystallform som aktiv bestanddel i medikamenter for behandling av inflammatoriske eller obstruktive luftveissykdommer.
NO20091231A 2006-08-31 2009-03-24 Polymorf av (R)-3-(2-hydroksy-2, 2-difenyl-acetoksy)-1-(isoksazol-S-ylcarbamoyl-metyl)-1-azoni A-bicyklo-[2,2,2]oktanbromid NO20091231L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119883A EP1900737A1 (en) 2006-08-31 2006-08-31 Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
PCT/EP2007/007560 WO2008025541A1 (en) 2006-08-31 2007-08-29 Polymorph of (r) -3- (2-hydroxy-2, 2-diphenyl-acetoxy) -1- (isoxazol-s-ylcarbamoyl-methyl) -1-azoni a-bicyclo- [2.2.2] octane bromide

Publications (1)

Publication Number Publication Date
NO20091231L true NO20091231L (no) 2009-03-25

Family

ID=37685707

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091231A NO20091231L (no) 2006-08-31 2009-03-24 Polymorf av (R)-3-(2-hydroksy-2, 2-difenyl-acetoksy)-1-(isoksazol-S-ylcarbamoyl-metyl)-1-azoni A-bicyklo-[2,2,2]oktanbromid

Country Status (21)

Country Link
US (1) US20090264461A1 (no)
EP (2) EP1900737A1 (no)
JP (1) JP2010501611A (no)
KR (1) KR20090051110A (no)
CN (1) CN101506205A (no)
AR (1) AR062582A1 (no)
AU (1) AU2007291515A1 (no)
BR (1) BRPI0716205A2 (no)
CA (1) CA2660983A1 (no)
CL (1) CL2007002524A1 (no)
GT (1) GT200900044A (no)
IL (1) IL196808A0 (no)
MA (1) MA31412B1 (no)
MX (1) MX2009002300A (no)
NO (1) NO20091231L (no)
PE (1) PE20080985A1 (no)
RU (1) RU2009111390A (no)
TN (1) TN2009000069A1 (no)
TW (1) TW200817399A (no)
WO (1) WO2008025541A1 (no)
ZA (1) ZA200900449B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044134A1 (es) * 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
RU2463048C2 (ru) * 2006-11-23 2012-10-10 Эргонекс Фарма Гмбх Фармацевтические композиции для лечения капиллярной артериопатии

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044134A1 (es) * 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.

Also Published As

Publication number Publication date
PE20080985A1 (es) 2008-09-05
AR062582A1 (es) 2008-11-19
BRPI0716205A2 (pt) 2013-11-12
CL2007002524A1 (es) 2008-07-11
EP2064210A1 (en) 2009-06-03
MX2009002300A (es) 2009-03-20
GT200900044A (es) 2012-01-16
TW200817399A (en) 2008-04-16
EP1900737A1 (en) 2008-03-19
KR20090051110A (ko) 2009-05-20
TN2009000069A1 (en) 2010-08-19
JP2010501611A (ja) 2010-01-21
IL196808A0 (en) 2009-11-18
CN101506205A (zh) 2009-08-12
US20090264461A1 (en) 2009-10-22
ZA200900449B (en) 2010-01-27
MA31412B1 (fr) 2010-06-01
RU2009111390A (ru) 2010-10-10
AU2007291515A1 (en) 2008-03-06
WO2008025541A1 (en) 2008-03-06
CA2660983A1 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
WO2006014665A3 (en) Arylpyrrolidine derivatives as nk-1/ssri antagonists
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
NO20083918L (no) Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser
NO20055219L (no) Nye forbindelser
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
MX2007005644A (es) Pirazolo-pirimidinas 1,4-sustituidas como inhibidores de cinasa.
WO2003064387A3 (en) Substituted indoles as alpha-1 agonists
EA201000805A1 (ru) Бис-(сульфониламино)производные в терапии 066
NO20043531L (no) Indazolforbindelser som er nyttige som proteinkinaseinhibitorer
DK2324008T3 (da) Diarylpyrazol som protein kinase inhibitorer
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
NO20084489L (no) Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet
NO20073628L (no) Pyridoner som er nyttige som inhibitorer av kinaser
NO20051100L (no) Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer
NO20083863L (no) Pyrazoler som 11-beta-hsd-1
NO20062691L (no) Azabicykliske heterocykler som cannabinoide reseptormodulatorer
WO2009155527A3 (en) Phosphatidylinositol 3 kinase inhibitors
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
CA2665931C (en) Hydrobenzamide derivatives as inhibitors of hsp90
NO20071619L (no) Fremgangsmate for fremstilling av indazol forbindelse
WO2008130879A3 (en) Tetrahydroindole and tetrahydroindazole derivatives
NO20083836L (no) N-hydroksyakrylamidforbindelser
TW200643013A (en) Pyrazoles
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application